vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and Five9, Inc. (FIVN). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $300.3M, roughly 1.2× Five9, Inc.). On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs 7.8%). Five9, Inc. produced more free cash flow last quarter ($77.3M vs $36.1M). Over the past eight quarters, Five9, Inc.'s revenue compounded faster (10.3% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Five9, Inc. is a leading global provider of cloud-native contact center software and solutions. It serves enterprises of all sizes across retail, healthcare, financial services, and technology sectors, offering omnichannel customer engagement tools, AI-powered automation, workforce management, and analytics to boost customer experience and operational efficiency.
ASIX vs FIVN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $300.3M |
| Net Profit | $-2.8M | — |
| Gross Margin | 7.6% | 55.4% |
| Operating Margin | -0.7% | 6.6% |
| Net Margin | -0.8% | — |
| Revenue YoY | 9.4% | 7.8% |
| Net Profit YoY | -892.9% | — |
| EPS (diluted) | $-0.11 | $0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $300.3M | ||
| Q3 25 | $374.5M | $285.8M | ||
| Q2 25 | $410.0M | $283.3M | ||
| Q1 25 | $377.8M | $279.7M | ||
| Q4 24 | $329.1M | $278.7M | ||
| Q3 24 | $398.2M | $264.2M | ||
| Q2 24 | $453.5M | $252.1M | ||
| Q1 24 | $336.8M | $247.0M |
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-2.6M | $18.0M | ||
| Q2 25 | $31.4M | $1.2M | ||
| Q1 25 | $23.3M | $576.0K | ||
| Q4 24 | $352.0K | — | ||
| Q3 24 | $22.3M | $-4.5M | ||
| Q2 24 | $38.9M | $-12.8M | ||
| Q1 24 | $-17.4M | $-7.1M |
| Q4 25 | 7.6% | 55.4% | ||
| Q3 25 | 6.8% | 55.0% | ||
| Q2 25 | 14.3% | 54.9% | ||
| Q1 25 | 14.2% | 55.0% | ||
| Q4 24 | 3.4% | 56.0% | ||
| Q3 24 | 14.4% | 53.8% | ||
| Q2 24 | 17.9% | 53.0% | ||
| Q1 24 | 0.9% | 53.6% |
| Q4 25 | -0.7% | 6.6% | ||
| Q3 25 | -0.9% | 5.6% | ||
| Q2 25 | 7.7% | -0.6% | ||
| Q1 25 | 7.7% | -1.9% | ||
| Q4 24 | -3.9% | 1.5% | ||
| Q3 24 | 7.5% | -5.8% | ||
| Q2 24 | 11.5% | -7.7% | ||
| Q1 24 | -7.0% | -8.4% |
| Q4 25 | -0.8% | — | ||
| Q3 25 | -0.7% | 6.3% | ||
| Q2 25 | 7.7% | 0.4% | ||
| Q1 25 | 6.2% | 0.2% | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 5.6% | -1.7% | ||
| Q2 24 | 8.6% | -5.1% | ||
| Q1 24 | -5.2% | -2.9% |
| Q4 25 | $-0.11 | $0.22 | ||
| Q3 25 | $-0.10 | $0.21 | ||
| Q2 25 | $1.15 | $0.01 | ||
| Q1 25 | $0.86 | $0.01 | ||
| Q4 24 | $0.02 | $0.16 | ||
| Q3 24 | $0.82 | $-0.06 | ||
| Q2 24 | $1.43 | $-0.17 | ||
| Q1 24 | $-0.65 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $232.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $785.8M |
| Total Assets | $1.7B | $1.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $232.1M | ||
| Q3 25 | $23.7M | $193.4M | ||
| Q2 25 | $18.4M | $205.5M | ||
| Q1 25 | $8.3M | $370.3M | ||
| Q4 24 | $19.6M | $362.5M | ||
| Q3 24 | $17.3M | $291.0M | ||
| Q2 24 | $12.1M | $175.7M | ||
| Q1 24 | $20.6M | $240.2M |
| Q4 25 | $815.2M | $785.8M | ||
| Q3 25 | $818.2M | $775.3M | ||
| Q2 25 | $823.7M | $717.4M | ||
| Q1 25 | $794.4M | $664.3M | ||
| Q4 24 | $774.6M | $622.2M | ||
| Q3 24 | $766.4M | $565.6M | ||
| Q2 24 | $746.6M | $525.9M | ||
| Q1 24 | $713.2M | $483.6M |
| Q4 25 | $1.7B | $1.8B | ||
| Q3 25 | $1.7B | $1.8B | ||
| Q2 25 | $1.6B | $1.7B | ||
| Q1 25 | $1.6B | $2.1B | ||
| Q4 24 | $1.6B | $2.1B | ||
| Q3 24 | $1.5B | $2.0B | ||
| Q2 24 | $1.5B | $1.9B | ||
| Q1 24 | $1.5B | $1.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $83.6M |
| Free Cash FlowOCF − Capex | $36.1M | $77.3M |
| FCF MarginFCF / Revenue | 10.0% | 25.8% |
| Capex IntensityCapex / Revenue | 7.7% | 2.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $201.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $83.6M | ||
| Q3 25 | $26.6M | $59.2M | ||
| Q2 25 | $21.1M | $35.1M | ||
| Q1 25 | $11.4M | $48.4M | ||
| Q4 24 | $64.2M | $49.8M | ||
| Q3 24 | $57.3M | $41.1M | ||
| Q2 24 | $50.2M | $19.9M | ||
| Q1 24 | $-36.2M | $32.4M |
| Q4 25 | $36.1M | $77.3M | ||
| Q3 25 | $66.0K | $48.7M | ||
| Q2 25 | $-7.2M | $31.6M | ||
| Q1 25 | $-22.6M | $43.7M | ||
| Q4 24 | $29.8M | $40.5M | ||
| Q3 24 | $26.8M | $26.7M | ||
| Q2 24 | $16.7M | $13.1M | ||
| Q1 24 | $-71.6M | $20.4M |
| Q4 25 | 10.0% | 25.8% | ||
| Q3 25 | 0.0% | 17.0% | ||
| Q2 25 | -1.7% | 11.1% | ||
| Q1 25 | -6.0% | 15.6% | ||
| Q4 24 | 9.1% | 14.5% | ||
| Q3 24 | 6.7% | 10.1% | ||
| Q2 24 | 3.7% | 5.2% | ||
| Q1 24 | -21.3% | 8.3% |
| Q4 25 | 7.7% | 2.1% | ||
| Q3 25 | 7.1% | 3.7% | ||
| Q2 25 | 6.9% | 1.2% | ||
| Q1 25 | 9.0% | 1.7% | ||
| Q4 24 | 10.4% | 3.3% | ||
| Q3 24 | 7.7% | 5.4% | ||
| Q2 24 | 7.4% | 2.7% | ||
| Q1 24 | 10.5% | 4.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | 3.29× | ||
| Q2 25 | 0.67× | 30.38× | ||
| Q1 25 | 0.49× | 84.00× | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | — | ||
| Q2 24 | 1.29× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
FIVN
Segment breakdown not available.
